IDO1 and breast carcinoma: Macrophages can also respond to immunotherapy by inhibiting NK cell‐mediated ADCC and T cell‐mediated cytotoxicity in breast cancers and lymphomas through the upregulation of PD‐L1 and IDO1 [38].